- |||||||||| CHS-006 / Coherus Biosci, Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci
Enrollment closed, Enrollment change, Combination therapy, Monotherapy, Metastases: Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Feb 20, 2024
P1/2, N=22, Active, not recruiting,
Recruiting --> Active, not recruiting | N=100 --> 22
- |||||||||| CHS-006 / Coherus Biosci, Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci
Enrollment open, Combination therapy, Monotherapy, Metastases: Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors (clinicaltrials.gov) - May 3, 2023
P1/2, N=100, Recruiting,
Recruiting --> Active, not recruiting | N=100 --> 22 Not yet recruiting --> Recruiting
- |||||||||| CHS-006 / Coherus Biosci, Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci, JS009 / Shanghai Junshi Biosci
Enrollment change, Trial withdrawal, Combination therapy, Monotherapy, Metastases: A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies (clinicaltrials.gov) - Apr 5, 2023
P1, N=0, Withdrawn,
Not yet recruiting --> Recruiting N=254 --> 0 | Not yet recruiting --> Withdrawn
- |||||||||| CHS-006 / Coherus Biosci, Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci, JS009 / Shanghai Junshi Biosci
New P1 trial, Combination therapy, Monotherapy, Metastases: A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies (clinicaltrials.gov) - Dec 14, 2022
P1, N=254, Not yet recruiting,
- |||||||||| Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci
Enrollment change, Trial withdrawal, Combination therapy, Monotherapy, Metastases: A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies (clinicaltrials.gov) - May 30, 2022
P1, N=0, Withdrawn,
N=254 --> 0 | Not yet recruiting --> Withdrawn N=208 --> 0 | Not yet recruiting --> Withdrawn
|
